Navigation Links
Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners
Date:10/30/2008

Four Lucky People with Diabetes Will Meet Nick Jonas in Los Angeles and Become Part of "Team Jonas" at Diabetes Fundraiser

TARRYTOWN, N.Y., Oct. 30 /PRNewswire/ -- To kick off Diabetes Awareness Month, Bayer Diabetes Care announced that four people with diabetes have won the opportunity to meet teen pop sensation Nick Jonas of the Jonas Brothers after entering the national "Walk In Nick's Shoes" (W.I.N.S.) sweepstakes. These Grand Prize winners will meet Nick Jonas in Los Angeles and walk as "Team Jonas" at the Juvenile Diabetes Research Foundation (JDRF) Walk for the Cure in Los Angeles on November 1.

The W.I.N.S. sweepstakes is offered as part of the partnership between Bayer and Nick Jonas to provide young people and their families with the motivation and support they need to help simplify life with diabetes.

The Grand Prize winners include, Deborah Bullock, from Cumming, GA; Zachary Jensen, from Orange, CA; Vincent Pettinato, from Jamison, PA; Bryan Zielinski, from Muskego, WI.

Bayer is sending the four Grand Prize winners and their guests to Los Angeles, CA, where they will have breakfast with Nick and watch as he kicks off the opening ceremony at the JDRF Walk for the Cure event. The Grand Prize winners will also receive personal diabetes coaching support, through Bayer's partnership with Fit4D, an innovative service that provides personalized diabetes coaching with a team that includes Certified Diabetes Educators (CDEs), nurses, exercise physiologists, registered dietitians and personal trainers, who integrate motivational support with fitness and nutrition planning. Additionally, ten First Prize winners will receive a pair of sneakers autographed by Nick Jonas and 100 second prize winners will receive a special Nick's Simple Wins t-shirt.

"I'm looking forward to meeting the sweepstakes winners as they join other young people and their families to raise awareness and funds for juvenile diabetes," said Nick Jonas. "By
'/>"/>

SOURCE Bayer Diabetes Care
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Bayer Temporarily Suspends Global Trasylol(R) Marketing
8. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
9. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
10. Bayer Awards Making Science Make Sense Grant to Girl Scouts
11. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Richmond, Va. (May 22, 2012) Scientists ... be one step closer to developing a new ... that the targeted agents obatoclax and sorafenib kill ... when the drugs are administered individually., Recently published ... study led by Steven Grant, M.D., Shirley Carter ...
(Date:5/22/2012)... It,s quite common for a female song sparrow to ... male next door, but a new study shows that ... which is reported in The American Naturalist, ... on to have lower reproductive success than within-pair offspring. ... why ostensibly monogamous animals might be inclined to cheat. ...
(Date:5/22/2012)... the Medical College of Wisconsin have identified novel biomarkers ... radiation in large groups of people potentially exposed to ... and treatment. , The findings are published in the ... John E. Baker, Ph.D., professor of surgery, biochemistry, pharmacology ... the lead author of the study. , There is ...
(Date:5/22/2012)... weight-loss products are the types of dietary supplements most ... new study. Liver injury from medication is the ... and herbal supplements -- which do not require a ... online -- are used by up to 40 percent ... side effects are not well-known. In this study, ...
(Date:5/22/2012)... care units (ICUs) that have no or limited access ... patient outcomes by having the specialists, called intensivists, staff ... by researchers at the University of Pittsburgh School of ... find any incremental benefit of nighttime staffing in ICUs ... day. The findings were published online today in the ...
Breaking Medicine News(10 mins):Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:Body Building, Diet Supplements Linked to Liver Damage: Study 2Health News:Intensivists at night improve patient outcomes in some ICUs, says Pitt/UPMC team 2
... to eradicate fatal parasite; first vaccines delivered following major ... Melbourne researchers that could eradicate a fatal form of ... and could soon be commercially available thanks to multi-million ... causes 50 million tapeworm infections and 50,000 deaths from ...
... financial results -, LAVAL, QC, Oct. 29 /PRNewswire-FirstCall/ ... it will host a conference call on,Friday, November 7 ... 2008,financial results. Labopharm will report its third quarter 2008 ... same day., To access the conference call by ...
... Arizona Market, NORTH HOLLYWOOD, Calif., Oct. 29 ... ), a leading national physician,group practice company, announced ... in Mesa, Arizona. The group has an ongoing ... hospitalist,services to the PHO,s patients in the Phoenix ...
... Montague,("Berger") announced today that a class action lawsuit was ... on behalf of all purchasers of,American Depository Shares (evidenced ... the "Company") and all purchasers of,options to purchase Elan ... 29, 2008 (the "Class Period") charging Elan and certain ...
... of America, Inc.,(OTC Bulletin Board: CPCF), a company ... in endovascular procedures, today announced,that it is implementing ... its MedClose(TM) investigational-stage medical device. In,the roll out ... Medical,Product Service GmbH (MPS) of Germany to act ...
... Japan-based Sato Sports Plaza to investigate new muscle,training ... effort to expand,global health and fitness research and ... formed an international science and health,exchange to highlight ... program with Sato Sports Plaza of,Japan is the ...
Other Medicine News:Health News:Fight begins to eradicate fatal parasite; first vaccines delivered following major funding award 2Health News:Fight begins to eradicate fatal parasite; first vaccines delivered following major funding award 3Health News:Labopharm to host conference call Friday, November 7, 2008 at 8:30 a.m. (ET) 2Health News:IPC The Hospitalist Company Acquires Phoenix Area Practice 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 3Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 4Health News:CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System 2Health News:CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System 3Health News:New Program Internationalizes Health and Fitness Research 2
(Date:5/22/2012)... -- SmallCapVoice.com, Inc. announced today that a ... (PINKSHEETS: MJNA) is now available. The interview ... Recent company activity and highlights: ... of approximately $1.21 million on gross revenues ... March 31, 2012.  This represents a gross ...
(Date:5/22/2012)... Company (Nasdaq: PRGO;TASE) today announced that it has ... Drug Administration for its abbreviated new drug application ... generic equivalent of Gynazole·1®. Perrigo was the first applicant ... paragraph IV certification and is entitled to 180-days ... Pharmaceutical Company on a collaboration to launch the ...
(Date:5/22/2012)... May 22, 2012 Prime Therapeutics (Prime), a ... hired Jim DuCharme as chief financial officer (CFO). DuCharme ... company,s foundation for continued growth. "Jim brings ... of driving business performance within diverse health plans, including ... president and CEO at Prime. "Based on his strong ...
Breaking Medicine Technology:Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 3Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 4Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3Osteotech Reports Third Quarter 2009 Financial Results 6039 1Osteotech Reports Third Quarter 2009 Financial Results 6039 2Osteotech Reports Third Quarter 2009 Financial Results 6039 3Osteotech Reports Third Quarter 2009 Financial Results 6039 4Osteotech Reports Third Quarter 2009 Financial Results 6039 5Osteotech Reports Third Quarter 2009 Financial Results 6039 6Osteotech Reports Third Quarter 2009 Financial Results 6039 7Osteotech Reports Third Quarter 2009 Financial Results 6039 8November 2009 story tips from the US Department of Energys Oak Ridge National Laboratory 14746 1November 2009 story tips from the US Department of Energys Oak Ridge National Laboratory 14746 2November 2009 story tips from the US Department of Energys Oak Ridge National Laboratory 14746 3Research Findings Key for Understanding Interpreting Genetic Testing for Long QT Syndrome 60803 1Research Findings Key for Understanding Interpreting Genetic Testing for Long QT Syndrome 60803 2Research Findings Key for Understanding Interpreting Genetic Testing for Long QT Syndrome 60803 3
... NEW HAVEN, Conn., Aug. 5 Rib-X ... company focused on the,discovery and development of ... announced today that company,representatives are giving three ... Research Conference on Medicinal Chemistry, August 3-8, ...
... 5 Nexgen Spine, a leading,developer of innovative ... disease, announced today that it has received CE ... in the European,Union., "We are delighted that ... approval," said Alastair Clemow, Ph.D., President and CEO,of ...
Other Medicine Technology:Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 2Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 3Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: